BMA: vaccine ‘breakthrough’ brings ‘widespread protection a step closer’
First interim analysis from phase 3 study finds vaccine candidate against COVID-19 to be 90% effective.
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
